By AdminM
by Brian Shilhavy
Editor, Health Impact News
Following a June, 2018 “Priority Review” by the FDA to approve Merck’s Gardasil 9 vaccine to be expanded to women and men, ages 27 to 45, after 10 years of the FDA denying Merck’s request to expand the Gardasil market to adults, the FDA approved Gardasil 9 to be expanded to adults, aged 27 to 45, on October 8, 2018.
Granting approval to a vaccine after a “Priority Review” by the FDA in only 3 months is a “fast nod” according to FiercePharma, the market trade publication …read more
Source: Health Impact News
- Rating:
- Views:199 views
- Categories: Health
Thanks! Share it with your friends!
Tweet
Share
Pin It
LinkedIn
Google+
Reddit
Tumblr